The Everolimus-Transplant Exit Strategy Trial (E-TEST)

NCT01636466 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Feasibility

Conditions

Kidney Failure, Chronic

Interventions

DRUG: Everolimus

Sponsor

Ashtar Chami

Collaborators

[object Object]